Clues pointing to simple hysterectomy to treat early-stage cervical cancer

Oncology Reports

Volumn 22, Issue 4, 2009, Pages 927-934

  Coutant, Charles ^a   Cordier, Anne Gaël ^a   Guillo, Eric ^a   Ballester, Marcos ^a   Rouzier, Roman ^a   Daraï, Emile ^a  

^a HÔPITAL TENON   (France)

Author keywords

Early cervical carcinoma; Fertility sparing treatment; Parametrectomy; Parametrial involvement; Sentinel lymph node

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH VESSEL; METASTASIS; OPERATION DURATION; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; UTERINE CERVICAL NEOPLASMS;

EID: 70350400222     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000519     Document Type: Article

References (29)

1. Piver MS, Rutledge F and Smith JP: Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44: 265-272, 1974.
2. Plante M and Roy M: New approaches in the surgical management of early stage cervical cancer. Curr Opin Obstet Gynecol 13: 41-46, 2001.
3. Strnad P, Robova H, Skapa P, et al: A prospective study of sentinel lymph node status and parametrial involvement in patients with small tumour volume cervical cancer. Gynecol Oncol 109: 280-284, 2008.
4. Hockel M: Do we need a new classification for radical hysterectomy? Insights in surgical anatomy and local tumor spread from human embryology. Gynecol Oncol 107: S106-S112, 2007.
5. Touboul C, Fauconnier A, Zareski E, Bouhanna P and Darai E: The lateral infraureteral parametrium: myth or reality? Am J Obstet Gynecol 199: 242 E241-E246, 2008.
6. Kinney WK, Hodge DO, Egorshin EV, Ballard DJ and Podratz KC: Identification of a low-risk subset of patients with stage IB invasive squamous cancer of the cervix possibly suited to less radical surgical treatment. Gynecol Oncol 57: 3-6, 1995.
7. Landoni F, Maneo A, Cormio G, et al: Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol 80: 3-12, 2001.
8. Magrina JF, Goodrich MA, Weaver AL and Podratz KC: Modified radical hysterectomy: morbidity and mortality. Gynecol Oncol 59: 277-282, 1995.
9. Benedetti-Panici P, Maneschi F, D'Andrea G, et al: Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study. Cancer 88: 2267-2274, 2000.
10. Delgado G, Bundy BN, Fowler WC Jr, et al: A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol 35: 314-320, 1989.
11. Stegeman M, Louwen M, van der Velden J, et al: The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy. Gynecol Oncol 105: 475-480, 2007.
12. Averette HE, Nguyen HN, Donato DM, et al: Radical hysterectomy for invasive cervical cancer. A 25-year prospective experience with the Miami technique. Cancer 71: 1422-1437, 1993.
13. Panici PB, Angioli R, Palaia I, et al: Tailoring the parametrectomy in stages IA2-IB1 cervical carcinoma: is it feasible and safe? Gynecol Oncol 96: 792-798, 2005.
14. Sood AK, Nygaard I, Shahin MS, Sorosky JI, Lutgendorf SK and Rao SS: Anorectal dysfunction after surgical treatment for cervical cancer. J Am Coll Surg 195: 513-519, 2002.
15. Coutant C, Barranger E, Cortez A, et al: Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer. Ann Oncol 18: 1513-1517, 2007.
16. Darai E, Rouzier R, Ballester M, Barranger E and Coutant C: Sentinel lymph node biopsy in gynaecological cancers: the importance of micrometastases in cervical cancer. Surg Oncol 17: 227-235, 2008.
17. Schwartz GF, Guiliano AE and Veronesi U: Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19-22, 2001, Philadelphia, PA, USA. Breast J 8: 124-138, 2002.
18. Marchiole P, Buenerd A, Benchaib M, Nezhat K, Dargent D and Mathevet P: Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study. Gynecol Oncol 97: 727-732, 2005.
19. Marchiole P, Buenerd A, Scoazec JY, Dargent D and Mathevet P: Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer 100: 2154-2159, 2004.
20. Selman TJ, Luesley DM, Murphy DJ and Mann CH: Is radical hysterectomy for early stage cervical cancer an outdated operation? BJOG 112: 363-365, 2005.
21. Wright JD, Grigsby PW, Brooks R, et al: Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer 110: 1281-1286, 2007.
22. Covens A, Rosen B, Murphy J, et al: How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol 84: 145-149, 2002.
23. Sonoda Y, Abu-Rustum NR, Gemignani ML, et al: A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible? Gynecol Oncol 95: 534-538, 2004.
24. Rob L, Charvata M, Robova H, et al: Sentinel lymph node identification (SLNI) in the management of conservative surgery in early cervical cancer: is it acceptable? Gynecol Oncol 99: S147-S148, 2005.
25. Bjornsson BL, Nelson BE, Reale FR and Rose PG: Accuracy of frozen section for lymph node metastasis in patients undergoing radical hysterectomy for carcinoma of the cervix. Gynecol Oncol 51: 50-53, 1993.
26. Morice P, Sabourin JC, Castaigne D, et al: Frozen section of lymph nodes in uterine cervical carcinoma. Clin Exp Pathol 47: 223-226, 1999.
27. Scholz HS, Lax SF, Benedicic C, Tamussino K and Winter R: Accuracy of frozen section examination of pelvic lymph nodes in patients with FIGO stage IB1 to IIB cervical cancer. Gynecol Oncol 90: 605-609, 2003.
28. Van Trappen PO, Gyselman VG, Lowe DG, et al: Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet 357: 15-20, 2001.
29. Postema S, Pattynama PM, van den Berg-Huysmans A, Peters LW, Kenter G and Trimbos JB: Effect of MRI on therapeutic decisions in invasive cervical carcinoma. Direct comparison with the pelvic examination as a preperative test. Gynecol Oncol 79: 485-489, 2000.